Johnson & Johnson Discontinues Phase 3 Study Evaluating Respiratory Syncytial Virus Vaccine
March 30th 2023The company announced the initiation of the EVERGREEN study, which was aimed to evaluate the efficacy, safety, and immunogenicity of the investigational respiratory syncytial virus vaccine, in 2021.
Read More
Pharmacy Focus: Public Health Matters - What is Public Health?
March 30th 2023This month's guest is Jennifer Lind, PharmD, MPH, MBA, a public health pharmacists, epidemiologist in the Medication Safety Program at the CDC, and commander in the United States Public Health Service Commissioned Corps.
Listen
Pharmacists Need to Be An Advocate, Recognized as Integral to Care Teams
March 29th 2023President (2022 to 2023) of the Hematology Oncology Pharmacists Association (HOPA) highlights the many ways that hematology/oncology pharmacists can collaborate with care teams to improve access to care at HOPA Annual Conference 2023 in Phoenix, Arizona from March 29 to April 1.
Watch